Sumitomo Dainippon Pharma: provides material assistance to Ukraine


March 22, 2022

Sumitomo Dainippon Pharma Co., Ltd.

Sumitomo Dainippon Pharma provides material assistance to Ukraine

Sumitomo Dainippon Pharma Co., Ltd. (head office: Osaka, Japan; representative director,

President and CEO: Hiroshi Nomura) made an announcement today regarding the provision of humanitarian aid to Ukraine. Based on a list of medicines of concern for shortages provided by Medicines for Europe, we have decided to donate a total of 3.5 million tablets of the antiepileptic agent “EXCEGRAN® 100 mg tablet” (brand name in Japan, generic name: zonisamide).

Sumitomo Dainippon Pharma will coordinate with the Ukrainian Embassy in Japan and others regarding the method of delivery.

Sumitomo Dainippon Pharma is also planning to donate meropenem hydrate (generic name, brand name in Japan: “MEROPEN®“), an antibiotic preparation based on carbapenem, since meropenem hydrate is included in the list of medicines of the Ukrainian Ministry of Health for which material assistance is required. A decision on the donation of meropenem hydrate will be confirmed a once the logistical feasibility and other details are clear, depending on local needs.

The security of people in Ukraine and the surrounding region is affected and they are going through a difficult time. We hope that this situation will be restored as soon as possible so that people can live in peace and security.


Business communication

Sumitomo Dainippon Pharma Co., Ltd.

TEL: +81-6-6203-1407 (Osaka); +81-3-5159-3300 (Tokyo)


Sumitomo Dainippon Pharma Co. Ltd. published this content on March 22, 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unmodified, on March 21, 2022 23:49:06 UTC.


Comments are closed.